Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

205 Views

054. HAI: C. difficile: Thursday, 12:15 - 1:30 p.m.

Poster Session: HAI: C. difficile

(678) **Changes in the Clostridioides difficile Infection (CDI) Treatment Pattern Pre-Post Clinical Guideline Update in 2021 and Variations across Hospitals**

Thursday, October 12, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Erik R. Dubberke, MD, MSPH

Professor
Washington University
Saint Louis, Missouri, United States

QL

Qinghua Li, PhD (she/her/hers)

Associate Director
Merck & Co., Inc.,
Rahway, New Jersey, United States
Engels N. Obi, PhD

Director Outcomes Research
Merck & Co., Inc
BASKING RIDGE, New Jersey, United States
Vladimir Turzhitsky, PhD

Director, Data Science and Outcomes Research
Merck & Co., Inc.
Boston, Massachusetts, United States
FS

Fakhar Siddiqui, MD, MBA

Merck & Co., Inc.
Rahway, New Jersey, United States
BN

Brian H. Nathanson, Ph.D.

President & CEO
OptiStatim LLC
Longmeadow, Massachusetts, United States